started · updated
BioPark Regensburg announces leadership transition
BioPark Regensburg GmbH is undergoing a leadership transition as Dr. Thomas Diefenthal steps down after nearly 30 years of managing the life sciences cluster. He is succeeded by Dr. Ilja Hagen, who has served as the cluster manager for the past 10 years.
Since its operational start in 1999, the BioPark has expanded from a single-person operation into a major hub with three buildings totaling 18,000 square meters. The cluster's focus has grown from biotechnology to include pharmaceuticals, medical technology, diagnostics, and the broader healthcare economy.
During the first 25 years, the region saw significant growth. The number of life science companies increased from 23 in 1999 to 72 by 2025, with employment rising from approximately 400 to 5,745. Total investments in the cluster's development reached 839 million euros by 2024, including 242 million euros in venture capital.
Entities
Bayern International · BioPark Regensburg GmbH · Dr. Ilja Hagen · Dr. Thomas Diefenthal · Regensburg
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] Total investment in life sciences development reached 839 million euros by 2024. www.presse-control.de · www.deutscherpresseindex.de · www.goingpublic.de
- [● 2 SOURCES] The cluster has expanded from biotechnology to include pharma, medical technology, diagnostics, and analytics. www.presse-control.de · www.deutscherpresseindex.de
- [● 2 SOURCES] Dr. Ilja Hagen is succeeding Dr. Thomas Diefenthal as managing director. www.presse-control.de · www.deutscherpresseindex.de
- [● 2 SOURCES] BioPark Regensburg GmbH was founded in 1998 as part of the BioRegio competition. www.presse-control.de · www.deutscherpresseindex.de
- [● 2 SOURCES] Of the 839 million euros invested, 242 million euros came from venture capital. www.presse-control.de · www.deutscherpresseindex.de
- [○ 1 SOURCE] The number of employees in the cluster grew from approximately 400 in 1999 to 5,745 by 2025. www.goingpublic.de
- [● 2 SOURCES] Dr. Thomas Diefenthal assumed operational management on April 1, 1999. www.presse-control.de · www.deutscherpresseindex.de
- [○ 1 SOURCE] The number of life science companies in the region grew from 23 in 1999 to 72 by 2025. www.goingpublic.de